BE542038A - - Google Patents
Info
- Publication number
- BE542038A BE542038A BE542038DA BE542038A BE 542038 A BE542038 A BE 542038A BE 542038D A BE542038D A BE 542038DA BE 542038 A BE542038 A BE 542038A
- Authority
- BE
- Belgium
- Prior art keywords
- neomycin
- tetracycline
- sep
- weight
- antibiotics
- Prior art date
Links
- 239000000203 mixture Substances 0.000 claims description 30
- 229930101283 tetracycline Natural products 0.000 claims description 25
- 229930193140 Neomycin Natural products 0.000 claims description 24
- 229960004927 neomycin Drugs 0.000 claims description 24
- 239000004098 Tetracycline Substances 0.000 claims description 22
- 229960002180 tetracycline Drugs 0.000 claims description 22
- 235000019364 tetracycline Nutrition 0.000 claims description 22
- 150000003522 tetracyclines Chemical class 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 6
- 230000001225 therapeutic effect Effects 0.000 claims description 4
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 claims description 3
- 229940053050 neomycin sulfate Drugs 0.000 claims description 3
- 239000011149 active material Substances 0.000 claims 4
- XMEVHPAGJVLHIG-FMZCEJRJSA-N chembl454950 Chemical compound [Cl-].C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H]([NH+](C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O XMEVHPAGJVLHIG-FMZCEJRJSA-N 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 229960004989 tetracycline hydrochloride Drugs 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 description 15
- 229940088710 antibiotic agent Drugs 0.000 description 15
- 244000005700 microbiome Species 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- GXGAKHNRMVGRPK-UHFFFAOYSA-N dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane Chemical compound [Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O GXGAKHNRMVGRPK-UHFFFAOYSA-N 0.000 description 1
- 239000011363 dried mixture Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229940099273 magnesium trisilicate Drugs 0.000 description 1
- 229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
- 235000019793 magnesium trisilicate Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- AJDUTMFFZHIJEM-UHFFFAOYSA-N n-(9,10-dioxoanthracen-1-yl)-4-[4-[[4-[4-[(9,10-dioxoanthracen-1-yl)carbamoyl]phenyl]phenyl]diazenyl]phenyl]benzamide Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2NC(=O)C(C=C1)=CC=C1C(C=C1)=CC=C1N=NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)NC1=CC=CC2=C1C(=O)C1=CC=CC=C1C2=O AJDUTMFFZHIJEM-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000001043 yellow dye Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE542038A true BE542038A (OSRAM) |
Family
ID=170837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE542038D BE542038A (OSRAM) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE542038A (OSRAM) |
-
0
- BE BE542038D patent/BE542038A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2268876A1 (fr) | Le (-)hydroxycitrate de magnesium, procede de preparation, applications, et compositions notamment pharmaceutiques le renfermant | |
| FR2472388A1 (fr) | Compositions pharmaceutiques contenant un produit corticosteroide | |
| US5618847A (en) | Medicinal feed for the systemic treatment of ectoparasitic and ectobacterial diseases of fish | |
| US20040244713A1 (en) | Method for treating animals or masses of water with compositions comprising quinone compounds | |
| CA2886652C (en) | Use of clothianidin in the reduction or elimination of sea lice | |
| FR2676363A1 (fr) | Antidote prophylactique contre les poisons organophosphoriques. | |
| CA2972175C (en) | Use of quillaja saponaria extracts for the prevention and control of bacterial infections in fish | |
| CA2335713C (en) | Oral dosage form | |
| BE542038A (OSRAM) | ||
| EP1858519A2 (de) | Kompatible solute enthaltende mittel zur oralen verwendung | |
| BE536902A (OSRAM) | ||
| FR2467596A1 (fr) | Compositions pharmaceutiques de tiaramide ou de son sel et d'un agent reglant la dissolution, a longue duree d'action | |
| RU2281768C2 (ru) | Лечебный корм для рыб | |
| FR2816841A1 (fr) | Nouvelles compositions pharmaceutiques a action antidiabetique et leur procede de preparation | |
| BE505709A (OSRAM) | ||
| FR2605221A1 (fr) | Compositions pharmaceutiques ou veterinaires contenant de la de(hydroxymethyl)-25 deoxy-25 oxo-25 monensine | |
| US5670513A (en) | Medicinal feed for the systemic treatment of ectoparasitic and ectobacterial diseases of fish | |
| FR3052065B1 (fr) | Combinaison de cineol et d'amoxicilline pour une utilisation dans le traitement d'une infection bacterienne | |
| JPH041132A (ja) | 魚類の細菌性疾患の予防・治療剤 | |
| BE1000256A6 (fr) | Composition pour le traitement de la peau, des cheveux et des ongles, son procede de preparation et son utilisation. | |
| BE825937A (fr) | Compositions antibacteriennes comprenant un compose de cephalosporine et un compose de penicilline | |
| WO2021245032A1 (en) | Nutraceutic composition containing limonene and a dry extract of cocoa fibre for the treatment of obesity | |
| JPH01296953A (ja) | ビタミンｃ組成物、それを添加した飼料およびその製造方法 | |
| BE607336A (OSRAM) | ||
| CN110916017A (zh) | 蟹肠炎病防治复合饲料及其应用 |